The effect of curcumin on human B-cell immortalization by Epstein-Barr virus

被引:0
|
作者
Ranjan, D [1 ]
Siquijor, A [1 ]
Johnston, TD [1 ]
Wu, GH [1 ]
Nagabhuskahn, M [1 ]
机构
[1] Univ Kentucky, Dept Surg, Transplantat Sect, Lexington, KY USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cyclosporine is a commonly used immunosuppressant in solid-organ transplantation. It is, however, associated with an increased incidence of Epstein-Barr virus (EBV)induced post-transplant lymphoproliferative disorder (PTLD). In this study, human B lymphocytes isolated from healthy volunteers were immortalized in vitro with EBV. The effect of oxidative stress mediated by cyclosporine A or hydrogen peroxide on in vitro B cell immortalization was studied by coculturing immortalized B cells with cyclosporine A and hydrogen peroxide. Curcumin, a phenolic extract of the spice turmeric, was then used to observe its effect on this process. We found that in vitro B-cell immortalization with EBV was promoted by the oxidative stress induced by cyclosporine A and hydrogen peroxide, with the maximum effect seen at concentrations of 500 ng/ml and 100 mu M, respectively. Curcumin blocked the B-cell immortalization in a dose-dependent fashion with nearly complete inhibition at 20 mu M. We conclude that, because both hydrogen peroxide and cyclosporine A strongly promote in vitro B-cell immortalization with EBV (the putative process responsible for PTLD) and curcumin, an extract of a common spice is an effective inhibitor of this process; curcumin may be an effective adjunct in the prevention of PTLD in the patients undergoing therapy with cyclosporine A.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 50 条
  • [1] The effect of curcumin on human B-cell immortalization by Epstein-Barr virus - Discussion
    McDonald, JC
    Rhoads, J
    Siguijor, A
    AMERICAN SURGEON, 1998, 64 (01) : 51 - 52
  • [2] Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization
    McFadden, Karyn
    Hafez, Amy Y.
    Kishton, Rigel
    Messinger, Joshua E.
    Nikitin, Pavel A.
    Rathmell, Jeffrey C.
    Luftig, Micah A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (06) : E782 - E790
  • [3] THE ROLE OF EPSTEIN-BARR VIRUS IN HUMAN B-CELL MALIGNANCIES
    BORNKAMM, GW
    HAEMATOLOGICA, 1987, 72 (06) : 67 - 70
  • [5] Limited nucleotide pools restrict Epstein-Barr virus-mediated B-cell immortalization
    Hafez, A. Y.
    Messinger, J. E.
    McFadden, K.
    Fenyofalvi, G.
    Shepard, C. N.
    Lenzi, G. M.
    Kim, B.
    Luftig, M. A.
    ONCOGENESIS, 2017, 6 : e349 - e349
  • [6] EPSTEIN-BARR VIRUS LATENT GENE-EXPRESSION DURING THE INITIATION OF B-CELL IMMORTALIZATION
    ALLDAY, MJ
    CRAWFORD, DH
    GRIFFIN, BE
    JOURNAL OF GENERAL VIROLOGY, 1989, 70 : 1755 - 1764
  • [7] IMMORTALIZATION OF HUMAN-LYMPHOCYTES BY EPSTEIN-BARR VIRUS
    MILLER, G
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1982, 55 (3-4): : 305 - 310
  • [8] EPSTEIN-BARR VIRUS - IMMORTALIZATION AND REPLICATION
    MILLER, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (19): : 1255 - 1256
  • [9] EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B-CELL LYMPHOPROLIFERATION
    HANTO, DW
    FRIZZERA, G
    GAJLPECZALSKA, KJ
    SIMMONS, RL
    TRANSPLANTATION, 1985, 39 (05) : 461 - 472
  • [10] The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization
    Yetming, Kristen D.
    Lupey-Green, Lena N.
    Biryukov, Sergei
    Hughes, David J.
    Marendy, Elessa M.
    Miranda, J. J. L.
    Sample, Jeffery T.
    JOURNAL OF VIROLOGY, 2020, 94 (17)